Donskov, Frede
Michaelson, M Dror
Puzanov, Igor
Davis, Mellar P
Bjarnason, Georg A
Motzer, Robert J
Goldstein, David
Lin, Xun
Cohen, Darrel P
Wiltshire, Robin
Rini, Brian I
Article History
Received: 5 January 2015
Revised: 18 August 2015
Accepted: 23 September 2015
First Online: 22 October 2015
Competing interests
: F Donskov has received research funding from Pfizer, Novartis, and GlaxoSmithKline. GA Bjarnason has received research funding and consulting fees from Pfizer. RJ Motzer has received research funding and consultant fees from Pfizer and has been compensated for expert testimony by Pfizer. D Goldstein has received research funding from Pfizer and GlaxoSmithKline. X Lin, DP Cohen, and R Wiltshire are full-time employees of Pfizer with Pfizer stock. BI Rini has received research funding and consulting fees from Pfizer. The other authors declare no conflict of interest.